Follow-up Study After 11 Years of Patients Who Were Included in the BENEFIT Trial (304747) With a First Demyelinating Event Suggestive of Multiple Sclerosis
Clinical trial NCT01795872 · COMPLETED
Trial details
- NCT number
- NCT01795872
- Sponsor
- Bayer
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2013-09-01
- Primary completion
- 2014-04-01
- Enrollment
- 278
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.